Qibang Sui
China Pharmaceutical University(CN)Chinese Academy of Sciences(CN)Shanghai Institute of Materia Medica(CN)Drug Discovery Laboratory (Norway)(NO)University of Chinese Academy of Sciences(CN)State Key Laboratory of Drug ResearchState Key Laboratory of Natural Medicine
Publications by Year
Research Areas
interferon and immune responses, Viral Infections and Vectors, Mosquito-borne diseases and control, Chemical Synthesis and Analysis, Inflammasome and immune disorders
Most-Cited Works
- → Sequence-based drug design as a concept in computational drug design(2023)111 cited
- → The STING antagonist H‐151 ameliorates psoriasis via suppression of STING/NF‐κB‐mediated inflammation(2021)98 cited
- → Discovery of an Orally Bioavailable STING Inhibitor with In Vivo Anti-Inflammatory Activity in Mice with STING-Mediated Inflammation(2025)14 cited
- → TiCl4-catalyzed deoxygenative reduction of amides to amines using ammonia borane(2023)9 cited
- → Design, synthesis, and structure−activity relationship studies of triazolo-pyrimidine derivatives as WRN inhibitors for the treatment of MSI tumors(2024)8 cited
- → Structure–Activity Relationship Study of 1H-Pyrrole-3-carbonitrile Derivatives as STING Receptor Agonists(2023)4 cited